| Year |
Citation |
Score |
| 2018 |
St-Pierre D, Cabana J, Holleran BJ, Besserer-Offroy É, Escher E, Guillemette G, Lavigne P, Leduc R. Angiotensin II cyclic analogs as tools to investigate ATR biased signaling mechanisms. Biochemical Pharmacology. PMID 29684376 DOI: 10.1016/J.Bcp.2018.04.021 |
0.494 |
|
| 2015 |
Cabana J, Holleran B, Leduc R, Escher E, Guillemette G, Lavigne P. Identification of Distinct Conformations of the Angiotensin-II Type 1 Receptor Associated with the Gq/11 Protein Pathway and the β-Arrestin Pathway Using Molecular Dynamics Simulations. The Journal of Biological Chemistry. 290: 15835-54. PMID 25934394 DOI: 10.1074/Jbc.M114.627356 |
0.547 |
|
| 2015 |
Domazet I, Holleran BJ, Richard A, Vandenberghe C, Lavigne P, Escher E, Leduc R, Guillemette G. Characterization of Angiotensin II Molecular Determinants Involved in AT1 Receptor Functional Selectivity. Molecular Pharmacology. 87: 982-95. PMID 25808928 DOI: 10.1124/Mol.114.097337 |
0.511 |
|
| 2014 |
Béliveau É, Lessard V, Guillemette G. STIM1 positively regulates the Ca2+ release activity of the inositol 1,4,5-trisphosphate receptor in bovine aortic endothelial cells. Plos One. 9: e114718. PMID 25506690 DOI: 10.1371/Journal.Pone.0114718 |
0.351 |
|
| 2013 |
Frégeau MO, Carrier M, Guillemette G. Mechanism of dopamine D2 receptor-induced Ca2+ release in PC-12 cells Cellular Signalling. 25: 2871-2877. PMID 24055909 DOI: 10.1016/J.Cellsig.2013.08.021 |
0.321 |
|
| 2013 |
Fillion D, Cabana J, Guillemette G, Leduc R, Lavigne P, Escher E. Structure of the human angiotensin II type 1 (AT1) receptor bound to angiotensin II from multiple chemoselective photoprobe contacts reveals a unique peptide binding mode Journal of Biological Chemistry. 288: 8187-8197. PMID 23386604 DOI: 10.1074/Jbc.M112.442053 |
0.581 |
|
| 2013 |
Cabana J, Holleran B, Beaulieu ME, Leduc R, Escher E, Guillemette G, Lavigne P. Critical hydrogen bond formation for activation of the angiotensin ii type 1 receptor Journal of Biological Chemistry. 288: 2593-2604. PMID 23223579 DOI: 10.1074/Jbc.M112.395939 |
0.545 |
|
| 2012 |
Elkoreh G, Blais V, Béliveau E, Guillemette G, Denault JB. Type 1 inositol-1,4,5-trisphosphate receptor is a late substrate of caspases during apoptosis. Journal of Cellular Biochemistry. 113: 2775-84. PMID 22473799 DOI: 10.1002/Jcb.24155 |
0.383 |
|
| 2011 |
Béliveau È, Lapointe F, Guillemette G. The activation state of the inositol 1,4,5-trisphosphate receptor regulates the velocity of intracellular Ca2+ waves in bovine aortic endothelial cells. Journal of Cellular Biochemistry. 112: 3722-31. PMID 21815194 DOI: 10.1002/Jcb.23301 |
0.307 |
|
| 2011 |
Frégeau MO, Régimbald-Dumas Y, Guillemette G. Positive regulation of inositol 1,4,5-trisphosphate-induced Ca2+ release by mammalian target of rapamycin (mTOR) in RINm5F cells. Journal of Cellular Biochemistry. 112: 723-33. PMID 21268094 DOI: 10.1002/Jcb.23006 |
0.334 |
|
| 2011 |
Régimbald-Dumas Y, Frégeau MO, Guillemette G. Mammalian target of rapamycin (mTOR) phosphorylates inositol 1,4,5-trisphosphate receptor type 2 and increases its Ca(2+) release activity. Cellular Signalling. 23: 71-9. PMID 20727967 DOI: 10.1016/J.Cellsig.2010.08.005 |
0.335 |
|
| 2010 |
Arguin G, Caron AZ, Elkoreh G, Denault JB, Guillemette G. The transcription factors NFAT and CREB have different susceptibilities to the reduced Ca2+ responses caused by the knock down of inositol trisphosphate receptor in HEK 293A cells. Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 26: 629-40. PMID 21063100 DOI: 10.1159/000322330 |
0.387 |
|
| 2010 |
Arsenault J, Cabana J, Fillion D, Leduc R, Guillemette G, Lavigne P, Escher E. Temperature dependent photolabeling of the human angiotensin II type 1 receptor reveals insights into its conformational landscape and its activation mechanism Biochemical Pharmacology. 80: 990-999. PMID 20599798 DOI: 10.1016/J.Bcp.2010.06.004 |
0.54 |
|
| 2010 |
Arsenault J, Lehoux J, Lanthier L, Cabana J, Guillemette G, Lavigne P, Leduc R, Escher E. A single-nucleotide polymorphism of alanine to threonine at position 163 of the human angiotensin II type 1 receptor impairs Losartan affinity Pharmacogenetics and Genomics. 20: 377-388. PMID 20436376 DOI: 10.1097/Fpc.0B013E32833A6D4A |
0.448 |
|
| 2010 |
Fillion D, Lemieux G, Basambombo LL, Lavigne P, Guillemette G, Leduc R, Escher E. The amino-terminus of angiotensin II contacts several ectodomains of the angiotensin II receptor AT1. Journal of Medicinal Chemistry. 53: 2063-75. PMID 20146480 DOI: 10.1021/Jm9015747 |
0.603 |
|
| 2010 |
Yan L, Holleran BJ, Lavigne P, Escher E, Guillemette G, Leduc R. Analysis of transmembrane domains 1 and 4 of the human angiotensin II AT1 receptor by cysteine-scanning mutagenesis. The Journal of Biological Chemistry. 285: 2284-93. PMID 19940150 DOI: 10.1074/Jbc.M109.077180 |
0.592 |
|
| 2009 |
Domazet I, Martin SS, Holleran BJ, Morin ME, Lacasse P, Lavigne P, Escher E, Leduc R, Guillemette G. The fifth transmembrane domain of angiotensin II Type 1 receptor participates in the formation of the ligand-binding pocket and undergoes a counterclockwise rotation upon receptor activation. The Journal of Biological Chemistry. 284: 31953-61. PMID 19773549 DOI: 10.1074/Jbc.M109.051839 |
0.601 |
|
| 2009 |
Clément M, Cabana J, Holleran BJ, Leduc R, Guillemette G, Lavigne P, Escher E. Activation induces structural changes in the liganded angiotensin II type 1 receptor Journal of Biological Chemistry. 284: 26603-26612. PMID 19635801 DOI: 10.1074/Jbc.M109.012922 |
0.57 |
|
| 2009 |
Holleran BJ, Domazet I, Beaulieu ME, Yan LP, Guillemette G, Lavigne P, Escher E, Leduc R. Identification of transmembrane domain 6 & 7 residues that contribute to the binding pocket of the urotensin II receptor. Biochemical Pharmacology. 77: 1374-82. PMID 19426676 DOI: 10.1016/J.Bcp.2009.01.013 |
0.594 |
|
| 2009 |
Clément M, Guillemette G, Leduc R, Escher E. Structural changes in the binding pocket of the liganded angiotensin II receptor AT1 during activation. Advances in Experimental Medicine and Biology. 611: 341-2. PMID 19400219 DOI: 10.1007/978-0-387-73657-0_152 |
0.539 |
|
| 2009 |
Arsenault J, Renaud MP, Clément M, Fillion D, Guillemette G, Leduc R, Lavigne P, Escher E. Temperature-induced ligand contact point variations of the hAT1 receptor and of the constitutively active mutant N111G-hAT1. Advances in Experimental Medicine and Biology. 611: 339-40. PMID 19400218 DOI: 10.1007/978-0-387-73657-0_151 |
0.453 |
|
| 2009 |
Fillion D, Guillemette G, Leduc R, Escher E. Photoprobe peptides to map the interactions of angiotensin II with its receptor AT1. Advances in Experimental Medicine and Biology. 611: 329-30. PMID 19400214 DOI: 10.1007/978-0-387-73657-0_147 |
0.452 |
|
| 2009 |
Domazet I, Holleran BJ, Martin SS, Lavigne P, Leduc R, Escher E, Guillemette G. The second transmembrane domain of the human type 1 angiotensin II receptor participates in the formation of the ligand binding pocket and undergoes integral pivoting movement during the process of receptor activation. The Journal of Biological Chemistry. 284: 11922-9. PMID 19276075 DOI: 10.1074/Jbc.M808113200 |
0.598 |
|
| 2009 |
Nguyen N, Francoeur N, Chartrand V, Klarskov K, Guillemette G, Boulay G. Insulin promotes the association of heat shock protein 90 with the inositol 1,4,5-trisphosphate receptor to dampen its Ca2+ release activity. Endocrinology. 150: 2190-6. PMID 19147678 DOI: 10.1210/En.2008-1167 |
0.392 |
|
| 2009 |
Béliveau E, Guillemette G. Microfilament and microtubule assembly is required for the propagation of inositol trisphosphate receptor-induced Ca2+ waves in bovine aortic endothelial cells. Journal of Cellular Biochemistry. 106: 344-52. PMID 19097121 DOI: 10.1002/Jcb.22011 |
0.322 |
|
| 2009 |
Cuerrier CM, Benoit M, Guillemette G, Gobeil F, Grandbois M. Real-time monitoring of angiotensin II-induced contractile response and cytoskeleton remodeling in individual cells by atomic force microscopy. PflüGers Archiv : European Journal of Physiology. 457: 1361-72. PMID 18953565 DOI: 10.1007/S00424-008-0596-0 |
0.461 |
|
| 2008 |
Blanchard AP, Guillemette G, Boulay G. Memantine potentiates agonist-induced Ca2+ responses in HEK 293 cells. Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 22: 205-14. PMID 18769047 DOI: 10.1159/000149798 |
0.399 |
|
| 2008 |
Proulx CD, Holleran BJ, Boucard AA, Escher E, Guillemette G, Leduc R. Mutational analysis of the conserved Asp2.50 and ERY motif reveals signaling bias of the urotensin II receptor. Molecular Pharmacology. 74: 552-61. PMID 18509066 DOI: 10.1124/Mol.108.045054 |
0.757 |
|
| 2008 |
Li H, Armando I, Yu P, Escano C, Mueller SC, Asico L, Pascua A, Lu Q, Wang X, Villar VA, Jones JE, Wang Z, Periasamy A, Lau YS, Soares-da-Silva P, ... ... Guillemette G, et al. Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cells. The Journal of Clinical Investigation. 118: 2180-9. PMID 18464932 DOI: 10.1172/Jci33637 |
0.344 |
|
| 2008 |
Proulx CD, Holleran BJ, Lavigne P, Escher E, Guillemette G, Leduc R. Biological properties and functional determinants of the urotensin II receptor. Peptides. 29: 691-9. PMID 18155322 DOI: 10.1016/J.Peptides.2007.10.027 |
0.525 |
|
| 2008 |
Leclerc PC, Proulx CD, Arguin G, Bélanger S, Gobeil F, Escher E, Leduc R, Guillemette G. Ascorbic acid decreases the binding affinity of the AT1 receptor for angiotensin II. American Journal of Hypertension. 21: 67-71. PMID 18091746 DOI: 10.1038/Ajh.2007.1 |
0.478 |
|
| 2007 |
Arsenault J, Renaud MP, Clément M, Fillion D, Guillemette G, Leduc R, Lavigne P, Escher E. Temperature-dependent variations of ligand-receptor contact points in hAT(1). Journal of Peptide Science : An Official Publication of the European Peptide Society. 13: 575-80. PMID 17600857 DOI: 10.1002/Psc.875 |
0.514 |
|
| 2007 |
Martin SS, Holleran BJ, Escher E, Guillemette G, Leduc R. Activation of the angiotensin II type 1 receptor leads to movement of the sixth transmembrane domain: analysis by the substituted cysteine accessibility method. Molecular Pharmacology. 72: 182-90. PMID 17446269 DOI: 10.1124/Mol.106.033670 |
0.562 |
|
| 2007 |
Chaloux B, Caron AZ, Guillemette G. Protein kinase A increases the binding affinity and the Ca2+ release activity of the inositol 1,4,5-trisphosphate receptor type 3 in RINm5F cells. Biology of the Cell / Under the Auspices of the European Cell Biology Organization. 99: 379-88. PMID 17373911 DOI: 10.1042/Bc20060121 |
0.427 |
|
| 2007 |
Arguin G, Regimbald-Dumas Y, Fregeau MO, Caron AZ, Guillemette G. Protein kinase C phosphorylates the inositol 1,4,5-trisphosphate receptor type 2 and decreases the mobilization of Ca2+in pancreatoma AR4-2J cells. The Journal of Endocrinology. 192: 659-68. PMID 17332533 DOI: 10.1677/Joe-06-0179 |
0.377 |
|
| 2007 |
Caron AZ, Chaloux B, Arguin G, Guillemette G. Protein kinase C decreases the apparent affinity of the inositol 1,4,5-trisphosphate receptor type 3 in RINm5F cells. Cell Calcium. 42: 323-31. PMID 17320950 DOI: 10.1016/J.Ceca.2007.01.002 |
0.424 |
|
| 2007 |
Regimbald-Dumas Y, Arguin G, Fregeau MO, Guillemette G. cAMP-dependent protein kinase enhances inositol 1,4,5-trisphosphate-induced Ca2+ release in AR4-2J cells. Journal of Cellular Biochemistry. 101: 609-18. PMID 17203464 DOI: 10.1002/Jcb.21221 |
0.366 |
|
| 2006 |
Clément M, Chamberland C, Pérodin J, Leduc R, Guillemette G, Escher E. The active and the inactive form of the hAT1 receptor have an identical ligand-binding environment: an MPA study on a constitutively active angiotensin II receptor mutant. Journal of Receptor and Signal Transduction Research. 26: 417-33. PMID 17118790 DOI: 10.1080/10799890600923195 |
0.605 |
|
| 2006 |
Leclerc PC, Lanctot PM, Auger-Messier M, Escher E, Leduc R, Guillemette G. S-nitrosylation of cysteine 289 of the AT1 receptor decreases its binding affinity for angiotensin II. British Journal of Pharmacology. 148: 306-13. PMID 16565729 DOI: 10.1038/Sj.Bjp.0706725 |
0.545 |
|
| 2006 |
Lanctôt PM, Leclerc PC, Escher E, Guillemette G, Leduc R. Role of N-glycan-dependent quality control in the cell-surface expression of the AT1 receptor. Biochemical and Biophysical Research Communications. 340: 395-402. PMID 16364240 DOI: 10.1016/J.Bbrc.2005.12.016 |
0.478 |
|
| 2005 |
Auger-Messier M, Turgeon ES, Leduc R, Escher E, Guillemette G. The constitutively active N111G-AT1 receptor for angiotensin II modifies the morphology and cytoskeletal organization of HEK-293 cells. Experimental Cell Research. 308: 188-95. PMID 15896777 DOI: 10.1016/J.Yexcr.2005.04.015 |
0.537 |
|
| 2005 |
Clément M, Martin SS, Beaulieu ME, Chamberland C, Lavigne P, Leduc R, Guillemette G, Escher E. Determining the environment of the ligand binding pocket of the human angiotensin II type I (hAT1) receptor using the methionine proximity assay. The Journal of Biological Chemistry. 280: 27121-9. PMID 15890659 DOI: 10.1074/Jbc.M413653200 |
0.516 |
|
| 2005 |
Lanctot PM, Leclerc PC, Clément M, Auger-Messier M, Escher E, Leduc R, Guillemette G. Importance of N-glycosylation positioning for cell-surface expression, targeting, affinity and quality control of the human AT1 receptor. The Biochemical Journal. 390: 367-76. PMID 15869468 DOI: 10.1042/Bj20050189 |
0.503 |
|
| 2005 |
Moris MA, Caron AZ, Guillemette G, Rognan D, Schmitt M, Schlewer G. Synthesis of (+/-)-2-O-[4'-(N-9''-purinyl)butyl] myo-inositol 1,4,5-tris(phosphate), a potent full agonist at the D-myo-inositol 1,4,5-tris(phosphate) receptor. Journal of Medicinal Chemistry. 48: 1251-5. PMID 15715492 DOI: 10.1021/Jm049458S |
0.337 |
|
| 2005 |
Guillemette J, Caron AZ, Regimbald-Dumas Y, Arguin G, Mignery GA, Boulay G, Guillemette G. Expression of a truncated form of inositol 1,4,5-trisphosphate receptor type III in the cytosol of DT40 triple inositol 1,4,5-trisphosphate receptor-knockout cells. Cell Calcium. 37: 97-104. PMID 15589990 DOI: 10.1016/J.Ceca.2004.03.005 |
0.423 |
|
| 2005 |
Proulx CD, Simaan M, Escher E, Laporte SA, Guillemette G, Leduc R. Involvement of a cytoplasmic-tail serine cluster in urotensin II receptor internalization. The Biochemical Journal. 385: 115-23. PMID 15458389 DOI: 10.1042/Bj20040807 |
0.588 |
|
| 2004 |
Martin SS, Boucard AA, Clément M, Escher E, Leduc R, Guillemette G. Analysis of the third transmembrane domain of the human type 1 angiotensin II receptor by cysteine scanning mutagenesis. The Journal of Biological Chemistry. 279: 51415-23. PMID 15452107 DOI: 10.1074/Jbc.M407965200 |
0.805 |
|
| 2004 |
Auger-Messier M, Arguin G, Chaloux B, Leduc R, Escher E, Guillemette G. Down-regulation of inositol 1,4,5-trisphosphate receptor in cells stably expressing the constitutively active angiotensin II N111G-AT(1) receptor. Molecular Endocrinology (Baltimore, Md.). 18: 2967-80. PMID 15331757 DOI: 10.1210/Me.2003-0488 |
0.497 |
|
| 2004 |
Moris MA, Caron AZ, Guillemette G, Schlewer G. Synthesis and binding properties of cyclopentane analogues of myo-inositol 1,4,5-tris(phosphate). Bioorganic & Medicinal Chemistry. 12: 3995-4001. PMID 15246076 DOI: 10.1016/J.Bmc.2004.06.005 |
0.378 |
|
| 2003 |
Auger-Messier M, Clement M, Lanctot PM, Leclerc PC, Leduc R, Escher E, Guillemette G. The constitutively active N111G-AT1 receptor for angiotensin II maintains a high affinity conformation despite being uncoupled from its cognate G protein Gq/11alpha. Endocrinology. 144: 5277-84. PMID 12960024 DOI: 10.1210/En.2003-0677 |
0.59 |
|
| 2003 |
Boucard AA, Roy M, Beaulieu ME, Lavigne P, Escher E, Guillemette G, Leduc R. Constitutive activation of the angiotensin II type 1 receptor alters the spatial proximity of transmembrane 7 to the ligand-binding pocket. The Journal of Biological Chemistry. 278: 36628-36. PMID 12842881 DOI: 10.1074/Jbc.M305952200 |
0.8 |
|
| 2003 |
Caron AZ, Arguin G, Guillemette G. Angiotensin IV interacts with a juxtamembrane site on AT(4)/IRAP suggesting an allosteric mechanism of enzyme modulation. Regulatory Peptides. 113: 9-15. PMID 12686456 DOI: 10.1016/S0167-0115(02)00294-X |
0.55 |
|
| 2003 |
Boucard AA, Sauvé SS, Guillemette G, Escher E, Leduc R. Photolabelling the rat urotensin II/GPR14 receptor identifies a ligand-binding site in the fourth transmembrane domain. The Biochemical Journal. 370: 829-38. PMID 12495432 DOI: 10.1042/Bj20021566 |
0.792 |
|
| 2002 |
Rihakova L, Deraët M, Auger-Messier M, Pérodin J, Boucard AA, Guillemette G, Leduc R, Lavigne P, Escher E. Methionine proximity assay, a novel method for exploring peptide ligand-receptor interaction. Journal of Receptor and Signal Transduction Research. 22: 297-313. PMID 12503623 DOI: 10.1081/Rrs-120014603 |
0.783 |
|
| 2002 |
Pérodin J, Deraët M, Auger-Messier M, Boucard AA, Rihakova L, Beaulieu ME, Lavigne P, Parent JL, Guillemette G, Leduc R, Escher E. Residues 293 and 294 are ligand contact points of the human angiotensin type 1 receptor. Biochemistry. 41: 14348-56. PMID 12450401 DOI: 10.1021/Bi0258602 |
0.797 |
|
| 2002 |
Leclerc PC, Auger-Messier M, Lanctot PM, Escher E, Leduc R, Guillemette G. A polyaromatic caveolin-binding-like motif in the cytoplasmic tail of the type 1 receptor for angiotensin II plays an important role in receptor trafficking and signaling. Endocrinology. 143: 4702-10. PMID 12446598 DOI: 10.1210/En.2002-220679 |
0.585 |
|
| 2002 |
Deraët M, Rihakova L, Boucard A, Pèrodin J, Sauvé S, Mathieu AP, Guillemette G, Leduc R, Lavigne P, Escher E. Angiotensin II is bound to both receptors AT1 and AT2, parallel to the transmembrane domains and in an extended form. Canadian Journal of Physiology and Pharmacology. 80: 418-25. PMID 12056548 DOI: 10.1139/Y02-060 |
0.793 |
|
| 2002 |
Laflamme K, Domingue O, Guillemette BI, Guillemette G. Immunohistochemical localization of type 2 inositol 1,4,5-trisphosphate receptor to the nucleus of different mammalian cells. Journal of Cellular Biochemistry. 85: 219-28. PMID 11891865 DOI: 10.1002/Jcb.10124 |
0.435 |
|
| 2001 |
Pérodin J, Boucard AA, Leduc R, Escher E, Guillemette G. Assays for radiolabel-photoaffinity labeling of Angiotensin receptors. Methods in Molecular Medicine. 51: 297-303. PMID 21331725 DOI: 10.1385/1-59259-087-X:297 |
0.755 |
|
| 2001 |
Bernatchez PN, Allen BG, Gélinas DS, Guillemette G, Sirois MG. Regulation of VEGF-induced endothelial cell PAF synthesis: Role of p42/44 MAPK, p38 MAPK and PI3K pathways British Journal of Pharmacology. 134: 1253-1262. PMID 11704645 DOI: 10.1038/Sj.Bjp.0704367 |
0.329 |
|
| 2001 |
Poirier SN, Poitras M, Chorvatova A, Payet MD, Guillemette G. FK506 blocks intracellular Ca2+ oscillations in bovine adrenal glomerulosa cells Biochemistry. 40: 6486-6492. PMID 11371212 DOI: 10.1021/Bi010207K |
0.468 |
|
| 2001 |
Poirier SN, Poitras M, Laflamme K, Guillemette G. Thiol-reactive agents biphasically regulate inositol 1,4,5-trisphosphate binding and Ca2+ release activities in bovine adrenal cortex microsomes Endocrinology. 142: 2614-2621. PMID 11356712 DOI: 10.1210/Endo.142.6.8195 |
0.486 |
|
| 2001 |
Farmer PJ, Bernier SG, Lepage A, Guillemette G, Regoli D, Sirois P. Permeability of endothelial monolayers to albumin is increased by bradykinin and inhibited by prostaglandins. American Journal of Physiology. Lung Cellular and Molecular Physiology. 280: L732-8. PMID 11238014 DOI: 10.1152/Ajplung.2001.280.4.L732 |
0.362 |
|
| 2001 |
Pelletier S, Dubé J, Villeneuve A, Gobeil F, Yang Q, Battistini B, Guillemette G, Sirois P. Prostaglandin E(2) increases cyclic AMP and inhibits endothelin-1 production/secretion by guinea-pig tracheal epithelial cells through EP(4) receptors. British Journal of Pharmacology. 132: 999-1008. PMID 11226130 DOI: 10.1038/Sj.Bjp.0703886 |
0.492 |
|
| 2000 |
Boucard AA, Wilkes BC, Laporte SA, Escher E, Guillemette G, Leduc R. Photolabeling identifies position 172 of the human AT(1) receptor as a ligand contact point: receptor-bound angiotensin II adopts an extended structure. Biochemistry. 39: 9662-70. PMID 10933782 DOI: 10.1021/Bi000597V |
0.806 |
|
| 2000 |
Gosselin MJ, Leclerc PC, Auger-Messier M, Guillemette G, Escher E, Leduc R. Molecular cloning of a ferret angiotensin II AT(1) receptor reveals the importance of position 163 for Losartan binding. Biochimica Et Biophysica Acta. 1497: 94-102. PMID 10838163 DOI: 10.1016/S0167-4889(00)00046-X |
0.562 |
|
| 2000 |
Pelletier S, Dubé J, Villeneuve A, Gobeil F, Bernier SG, Battistini B, Guillemette G, Sirois P. Adenosine induces cyclic-AMP formation and inhibits endothelin-1 production/secretion in guinea-pig tracheal epithelial cells through A(2B) adenosine receptors. British Journal of Pharmacology. 129: 243-50. PMID 10694229 DOI: 10.1038/Sj.Bjp.0702999 |
0.408 |
|
| 1999 |
Ballereau S, Guédat P, Poirier SN, Guillemette G, Spiess B, Schlewer G. Synthesis, acid-base behavior, and binding properties of 6-modified myo- inositol 1,4,5-tris(phosphate)s Journal of Medicinal Chemistry. 42: 4824-4835. PMID 10579845 DOI: 10.1021/Jm991084T |
0.38 |
|
| 1999 |
Briand SI, Neugebauer W, Guillemette G. Agonist-dependent AT(4) receptor internalization in bovine aortic endothelial cells. Journal of Cellular Biochemistry. 75: 587-97. PMID 10572242 DOI: 10.1002/(Sici)1097-4644(19991215)75:4<587::Aid-Jcb5>3.0.Co;2-Q |
0.817 |
|
| 1999 |
Lanctôt PM, Leclerc PC, Escher E, Leduc R, Guillemette G. Role of N-glycosylation in the expression and functional properties of human AT1 receptor. Biochemistry. 38: 8621-7. PMID 10393537 DOI: 10.1021/Bi9830516 |
0.545 |
|
| 1999 |
Laporte SA, Boucard AA, Servant G, Guillemette G, Leduc R, Escher E. Determination of peptide contact points in the human angiotensin II type I receptor (AT1) with photosensitive analogs of angiotensin II. Molecular Endocrinology (Baltimore, Md.). 13: 578-86. PMID 10194764 DOI: 10.1210/Mend.13.4.0270 |
0.806 |
|
| 1998 |
Briand SI, Bernier SG, Guillemette G. Monitoring of phospholipase A2 activation in cultured cells using tritiated arachidonic acid Methods in Molecular Biology (Clifton, N.J.). 105: 161-166. PMID 10427559 DOI: 10.1385/0-89603-491-7:161 |
0.728 |
|
| 1998 |
Briand SI, Bellemare JML, Bernier SG, Guillemette G. Study on the functionality and molecular properties of the AT4 receptor Endocrine Research. 24: 315-323. PMID 9888503 DOI: 10.3109/07435809809032611 |
0.823 |
|
| 1998 |
Chrétien L, Richard DE, Poirier SN, Paitras M, Guillemette G. Bovine adrenal glomerulosa cells express such a low level of functional B2 receptors that bradykinin does not significantly increase their aldosterone production Journal of Endocrinology. 156: 449-460. PMID 9582501 DOI: 10.1677/Joe.0.1560449 |
0.5 |
|
| 1998 |
Bouley R, Pérodin J, Plante H, Řihakova L, Bernier SG, Maletínská L, Guillemette G, Escher E. N- and C-terminal structure-activity study of angiotensin II on the angiotensin AT2 receptor European Journal of Pharmacology. 343: 323-331. PMID 9570482 DOI: 10.1016/S0014-2999(97)01549-5 |
0.57 |
|
| 1998 |
Servant G, Escher E, Guillemette G. The angiotensin II binding site on Mycoplasma hyorhynis is structurally distinct from mammalian AT1 and AT2 receptors. Regulatory Peptides. 73: 35-41. PMID 9537671 DOI: 10.1016/S0167-0115(97)01060-4 |
0.504 |
|
| 1998 |
Bernier SG, Bellemare JM, Escher E, Guillemette G. Characterization of AT4 receptor from bovine aortic endothelium with photosensitive analogues of angiotensin IV Biochemistry. 37: 4280-4287. PMID 9521751 DOI: 10.1021/Bi972863J |
0.543 |
|
| 1997 |
Chrétien L, Laporte SA, Escher E, Leduc R, Guillemette G. Use of LiCl in phospholipase C assays masks the impaired functionality of a mutant angiotensin II receptor. Cellular Signalling. 9: 379-82. PMID 9376218 DOI: 10.1016/S0898-6568(97)00032-6 |
0.551 |
|
| 1997 |
Bouley R, Gosselin M, Plante H, Servant G, Pérodin J, Arcand M, Guillemette G, Escher E. Characterization of a specific binding site for angiotensin II in chicken liver. Canadian Journal of Physiology and Pharmacology. 75: 568-75. PMID 9276130 DOI: 10.1139/Cjpp-75-6-568 |
0.415 |
|
| 1997 |
Richard DE, Laporte SA, Bernier SG, Leduc R, Guillemette G. Desensitization of AT1 receptor-mediated cellular responses requires long term receptor down-regulation in bovine adrenal glomerulosa cells Endocrinology. 138: 3828-3835. PMID 9275071 DOI: 10.1210/Endo.138.9.5409 |
0.533 |
|
| 1997 |
Richard DE, Chrétien L, Caron M, Guillemette G. Stimulation of the angiotensin II type I receptor on bovine adrenal glomerulosa cells activates a temperature-sensitive internalization-recycling pathway Molecular and Cellular Endocrinology. 129: 209-218. PMID 9202404 DOI: 10.1016/S0303-7207(97)00065-8 |
0.568 |
|
| 1997 |
Servant G, Laporte SA, Leduc R, Escher E, Guillemette G. Identification of angiotensin II-binding domains in the rat AT2 receptor with photolabile angiotensin analogs. The Journal of Biological Chemistry. 272: 8653-9. PMID 9079697 DOI: 10.1074/Jbc.272.13.8653 |
0.604 |
|
| 1996 |
Briand SI, Bernier SG, Guillemette G. Calcium-calmodulin plays a major role in bradykinin-induced arachidonic acid release by bovine aortic endothelial cells Journal of Cellular Biochemistry. 63: 292-301. PMID 8913880 DOI: 10.1002/(Sici)1097-4644(19961201)63:3<292::Aid-Jcb4>3.0.Co;2-S |
0.751 |
|
| 1996 |
Servant G, Dudley DT, Escher E, Guillemette G. Analysis of the role of N-glycosylation in cell-surface expression and binding properties of angiotensin II type-2 receptor of rat pheochromocytoma cells. The Biochemical Journal. 297-304. PMID 8546698 DOI: 10.1042/Bj3130297 |
0.574 |
|
| 1996 |
Guédat P, Poitras M, Spiess B, Guillemette G, Schlewer G. Rapid synthesis and properties of (±)-6-Deoxy-6-fluoro-myo-inositol-1,4,5-tris(phosphate) an analogue of myo-inositol-1,4,5-tris(phosphate) Bioorganic & Medicinal Chemistry Letters. 6: 1175-1178. DOI: 10.1016/0960-894X(96)00193-X |
0.34 |
|
| 1995 |
Bernier SG, Servant G, Boudreau M, Fournier A, Guillemette G. Characterization of a binding site for angiotensin IV on bovine aortic endothelial cells. European Journal of Pharmacology. 291: 191-200. PMID 8566170 DOI: 10.1016/0922-4106(95)90142-6 |
0.49 |
|
| 1995 |
Servant M, Guillemette G, Morisset J. Pharmacologic characterization of the inositol trisphosphate receptor in rat pancreas. Pancreas. 9: 591-8. PMID 7809014 DOI: 10.1097/00006676-199409000-00009 |
0.341 |
|
| 1995 |
Poitras M, Ribeiro-Do-Valle RM, Poirier SN, Guillemette G. Bidirectional activity of the endoplasmic reticulum Ca2+-ATPase of bovine adrenal cortex Biochemistry. 34: 9755-9761. PMID 7626646 DOI: 10.1021/Bi00030A013 |
0.32 |
|
| 1995 |
Servant M, Guillemette G, Morisset J. Pancreatic acinar-cell desensitization alters InsP3 production and Ca2+ mobilization under conditions where InsP3 receptor remains intact. The Biochemical Journal. 103-10. PMID 7529994 DOI: 10.1042/Bj3050103 |
0.504 |
|
| 1994 |
Ribeiro-do-Valle RM, Poitras M, Boulay G, Guillemette G. The important discrepancy between the apparent affinity observed in Ca2+ mobilization studies and the Kd measured in binding studies is a consequence of the quantal process by which inositol 1,4,5-trisphosphate releases Ca2+ from bovine adrenal cortex microsomes. Cell Calcium. 15: 79-88. PMID 8149408 DOI: 10.1016/0143-4160(94)90106-6 |
0.368 |
|
| 1994 |
Richard DE, Bernier S, Boulay G, Guillemette G. Selective interaction of chemical dyes with inositol 1,4,5-trisphosphate recognition sites Canadian Journal of Physiology and Pharmacology. 72: 174-181. PMID 8050059 DOI: 10.1139/Y94-027 |
0.395 |
|
| 1994 |
Boulay G, Chrétien L, Richard DE, Guillemette G. Short-term desensitization of the angiotensin II receptor of bovine adrenal glomerulosa cells corresponds to a shift from a high to a low affinity state Endocrinology. 135: 2130-2136. PMID 7956936 DOI: 10.1210/Endo.135.5.7956936 |
0.558 |
|
| 1994 |
Bernier SG, Fournier A, Guillemette G. A specific binding site recognizing a fragment of angiotensin II in bovine adrenal cortex membranes European Journal of Pharmacology. 271: 55-63. PMID 7698212 DOI: 10.1016/0014-2999(94)90264-X |
0.409 |
|
| 1994 |
Chrétien L, Guillemette G, Regoli D. Non-peptide angiotensin receptor antagonists bind to tachykinin NK3 receptors of rat and guinea pig brain. European Journal of Pharmacology. 256: 73-8. PMID 7517891 DOI: 10.1016/0014-2999(94)90618-1 |
0.523 |
|
| 1993 |
Bossé R, Servant G, Zhou LM, Boulay G, Guillemette G, Escher E. Sar1-p-benzoylphenylalanine-angiotensin, a new photoaffinity probe for selective labeling of the type 2 angiotensin receptor. Regulatory Peptides. 44: 215-23. PMID 8469775 DOI: 10.1016/0167-0115(93)90245-4 |
0.523 |
|
| 1993 |
Poitras M, Bernier S, Boulay G, Fournier A, Guillemette G. Interaction of benzene 1,2,4-trisphosphate with inositol 1,4,5-trisphosphate receptor and metabolizing enzymes. European Journal of Pharmacology. 244: 203-10. PMID 8384566 DOI: 10.1016/0922-4106(93)90145-Y |
0.473 |
|
| 1993 |
Tousignant C, Regoli D, Rhaleb NE, Jukic D, Guillemette G. 125I-Tyr,D-Arg[Hyp3,D-Phe7,Leu8]BK, a radiolabelled B2 antagonist specifically interacts with two distinct binding sites on epithelial membranes of guinea pig ileum. Agents and Actions. Supplements. 526-39. PMID 1334630 DOI: 10.1007/978-3-0348-7321-5_64 |
0.305 |
|
| 1993 |
Tousignant C, Chrétien L, Guillemette G, Regoli D. Characterization of NK-1 receptors in guinea pig and rat brain membranes with NK-1 peptides and a non-peptide antagonist. Brain Research. 596: 243-50. PMID 1281744 DOI: 10.1016/0006-8993(92)91554-R |
0.389 |
|
| 1992 |
Tousignant C, Guillemette G, Regoli D. Binding sites for [3H][Sar9, Met(O2)11]substance P in rat brain and guinea pig ileum. Brain Research. 560: 1-11. PMID 1722129 DOI: 10.1016/0006-8993(91)91207-H |
0.357 |
|
| 1992 |
Luong TT, Poitras M, Boulay G, Guillemette G. Interaction of polyanions with the recognition sites for inositol 1,4,5-trisphosphate in the bovine adrenal cortex. European Journal of Pharmacology. 208: 213-21. PMID 1663045 DOI: 10.1016/0922-4106(91)90098-3 |
0.394 |
|
| 1992 |
Tousignant C, Regoli D, Rhaleb NE, Jukic D, Guillemette G. Characterization of a novel binding site for 125I-Tyr-D-Arg-[Hyp3,D-Phe7,Leu8]bradykinin on epithelial membranes of guinea pig ileum. European Journal of Pharmacology. 225: 235-44. PMID 1325366 DOI: 10.1016/0922-4106(92)90025-Q |
0.358 |
|
| 1992 |
Luong TT, Boulay G, Guillemette G. Study on the stereoselectivity of inositol 1,4,5-trisphosphate recognition sites of bovine adrenal cortex. Canadian Journal of Physiology and Pharmacology. 70: 434-41. PMID 1323374 DOI: 10.1139/Y92-055 |
0.458 |
|
| 1991 |
de Brum-Fernandes AJ, Guillemette G, Sirois P. Leukotriene B4 binding sites in guinea-pig alveolar macrophages. Prostaglandins. 40: 515-27. PMID 2175041 DOI: 10.1016/0090-6980(90)90113-A |
0.378 |
|
| 1991 |
Tousignant C, Guillemette G, Barabé J, Rhaleb NE, Regoli D. Characterization of kinin binding sites: identity of B2 receptors in the epithelium and the smooth muscle of the guinea pig ileum. Canadian Journal of Physiology and Pharmacology. 69: 818-25. PMID 1655182 DOI: 10.1139/Y91-123 |
0.419 |
|
| 1990 |
Tousignant C, Guillemette G, Drapeau G, Regoli D. Comparison of binding assay and biological activity on a NK-1 system with new selective agonists. Neuropeptides. 14: 275-83. PMID 2482952 DOI: 10.1016/0143-4179(89)90057-7 |
0.399 |
|
| 1990 |
Boulay G, Gallo-Payet N, Guillemette G. Implication of phospholipase C in the steroidogenic action of angiotensin II European Journal of Pharmacology: Molecular Pharmacology. 189: 267-275. PMID 2177698 DOI: 10.1016/0922-4106(90)90119-I |
0.423 |
|
| 1990 |
Guillemette G, Favreau I, Lamontagne S, Boulay G. 2,3-Diphosphoglycerate is a nonselective inhibitor of inositol 1,4,5-trisphosphate action and metabolism. European Journal of Pharmacology. 188: 251-60. PMID 2163877 DOI: 10.1016/0922-4106(90)90009-M |
0.382 |
|
| 1989 |
Guillemette G, Boulay G, Gagnon S, Bosse R, Escher E. The peptide encoded by angiotensin II complementary RNA does not interfere with angiotensin II action. The Biochemical Journal. 261: 309. PMID 2775218 DOI: 10.1042/Bj2610309 |
0.343 |
|
| 1988 |
Guillemette G, Segui JA. Effects of pH, reducing and alkylating reagents on the binding and Ca2+ release activities of inositol 1,4,5-triphosphate in the bovine adrenal cortex. Molecular Endocrinology (Baltimore, Md.). 2: 1249-55. PMID 3265177 DOI: 10.1210/Mend-2-12-1249 |
0.427 |
|
| 1987 |
Cantau B, Guillemette G, Chicot D, Devilliers G. Vasopressin, angiotensin and adrenergic receptors of rat liver Golgi fractions--molecular weight of the angiotensin-receptor irreversible complex after in vitro and in vivo labelling. Molecular and Cellular Endocrinology. 51: 59-69. PMID 2954870 DOI: 10.1016/0303-7207(87)90119-5 |
0.411 |
|
| 1987 |
Catt KJ, Carson MC, Hausdorff WP, Leach-Harper CM, Baukal AJ, Guillemette G, Balla T, Aguilera G. Angiotensin II receptors and mechanisms of action in adrenal glomerulosa cells. Journal of Steroid Biochemistry. 27: 915-27. PMID 2826911 DOI: 10.1016/0022-4731(87)90168-3 |
0.462 |
|
| 1987 |
Guillemette G, Balla T, Baukal AJ, Catt KJ. Inositol 1,4,5-trisphosphate binds to a specific receptor and releases microsomal calcium in the anterior pituitary gland. Proceedings of the National Academy of Sciences of the United States of America. 84: 8195-9. PMID 2825180 DOI: 10.1073/PNAS.84.23.8195 |
0.323 |
|
| 1985 |
Guillemette G, Guillon G, Marie J, Pantaloni C, Balestre MN, Escher E, Jard S. Angiotensin-induced changes in the apparent size of rat liver angiotensin receptors. Journal of Receptor Research. 4: 267-81. PMID 6098656 DOI: 10.3109/10799898409042554 |
0.443 |
|
| 1985 |
Baukal AJ, Guillemette G, Rubin R, Spät A, Catt KJ. Binding sites for inositol trisphosphate in the bovine adrenal cortex. Biochemical and Biophysical Research Communications. 133: 532-8. PMID 3878710 |
0.315 |
|
| 1984 |
Guillemette G, Bernier M, Parent P, Leduc R, Escher E. Angiotensin II: dependence of hormone affinity on the electronegativity of a single side chain. Journal of Medicinal Chemistry. 27: 315-20. PMID 6699877 DOI: 10.1002/Chin.198432338 |
0.398 |
|
| 1984 |
Guillemette G, Escher E. Analysis of the adrenal angiotensin II receptor with the photoaffinity labeling method. Biochemistry. 22: 5591-6. PMID 6317023 DOI: 10.1021/Bi00293A021 |
0.553 |
|
| 1982 |
Escher E, Laczkó E, Guillemette G, Regoli D. Biological activities of photoaffinity labeling analogues of kinins and their irreversible effects on kinin receptors. Journal of Medicinal Chemistry. 24: 1409-13. PMID 6118437 DOI: 10.1002/Chin.198221327 |
0.487 |
|
| 1982 |
ESCHER E, LACZKO E, GUILLEMETTE G, REGOLI D. ChemInform Abstract: BIOLOGICAL ACTIVITIES OF PHOTOAFFINITY LABELING ANALOGS OF KININS AND THEIR IRREVERSIBLE EFFECTS ON KININ RECEPTORS Chemischer Informationsdienst. 13. DOI: 10.1002/CHIN.198221327 |
0.393 |
|
| 1981 |
Cordopatis P, Theodoropoulos D, Guillemette G, Escher E. Studies on position 1 of angiotensin II: effects on affinity and duration of action from alkyl amide substitution. Journal of Medicinal Chemistry. 24: 209-11. PMID 7205889 DOI: 10.1002/Chin.198128367 |
0.37 |
|
| 1980 |
Escher E, Guillemette G, Leukart O, Regoli D. Pharmacological properties of two analogues of angiotensin II containing carboranylalanine (Car). European Journal of Pharmacology. 66: 267-72. PMID 7418720 DOI: 10.1016/0014-2999(80)90458-6 |
0.524 |
|
| 1980 |
ESCHER EHF, GUILLEMETTE G. ChemInform Abstract: PHOTOAFFINITY LABELING OF THE ANGIOTENSIN II RECEPTOR. 3. RECEPTOR INACTIVATION WITH PHOTOLABILE HORMONE ANALOGS Chemischer Informationsdienst. 11. DOI: 10.1002/CHIN.198005388 |
0.488 |
|
| 1979 |
Escher EH, Guillemette G. Photoaffinity labeling of the angiotensin II receptor. 3. Receptor inactivation with photolabile hormone analogues. Journal of Medicinal Chemistry. 22: 1047-50. PMID 226704 DOI: 10.1021/Jm00195A007 |
0.488 |
|
| 1978 |
Escher EH, Nguyen TM, Guillemette G, Regoli DC. Specific and irreversible block of the myotropic action of angiotensin II. Nature. 275: 145-6. PMID 211425 DOI: 10.1038/275145A0 |
0.359 |
|
| Show low-probability matches. |